NITRODERM Side Effects

6263133-3 | Application Site Warmth, Migraine
on Jul 08, 2009 Female patient from UNITED STATES , weighting 140.0 lb, was treated with Nitroderm (View Usage). Patient experienced the following unwanted or unexpected effects: application site warmth, migraine (What is migraine?). Nitroderm dosage: 1 Every Day Different Spot.

6202623-6 | Cardiac Tamponade
Patient was taking Nitroderm (View Usage). Patient had the following side effects: cardiac tamponade on May 14, 2009 from SWITZERLAND Additional patient health information: Female patient , 81 years of age, . Nitroderm dosage: . During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), IRFEN (View Irfen Review and Irfen Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), TORASIS (View Torasis Review and Torasis Label ), NEXIUM (View Nexium Review and Nexium Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.

5760768-9 | Choking, Decreased Appetite, Dysphagia, Pneumonia Aspiration, Pyrexia, Salivary Hypersecretion, Somnolence, Weight Decreased
Adverse event was reported on May 27, 2008 by a Female patient taking Nitroderm (View Usage) (Dosage: Unk) . Location: JAPAN , 81 years of age, weighting 114.6 lb, After Nitroderm was administered, patient had the following side effects: choking (What is choking?), decreased appetite, dysphagia, pneumonia aspiration, pyrexia, salivary hypersecretion, somnolence, weight decreased. During the same period patient was treated with TIAPRIDE HYDROCHLORIDE (25mg/day) (View Tiapride Hydrochloride Review and Tiapride Hydrochloride Label ), CALCIUM CARBONATE (Unk) (View Calcium Carbonate Review and Calcium Carbonate Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), IRSOGLADINE MALEATE (Unk) (View Irsogladine Maleate Review and Irsogladine Maleate Label ), AMEZINIUM METILSULFATE (Unk) (View Amezinium Metilsulfate Review and Amezinium Metilsulfate Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), CARBOCISTEINE (Unk) (View Carbocisteine Review and Carbocisteine Label ), EPOGEN (View Epogen Review and Epogen Label ).

5751638-0 | Dysphagia, Pneumonia Aspiration
on May 21, 2008 Female patient from JAPAN , 81 years of age, weighting 114.6 lb, was treated with Nitroderm (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia, pneumonia aspiration. Nitroderm dosage: Unk. During the same period patient was treated with TIAPRIDE HYDROCHLORIDE (25mg/day) (View Tiapride Hydrochloride Review and Tiapride Hydrochloride Label ), CALCIUM CARBONATE (Unk) (View Calcium Carbonate Review and Calcium Carbonate Label ), OMEPRAZOLE (Unk) (View Omeprazole Review and Omeprazole Label ), IRSOGLADINE MALEATE (Unk) (View Irsogladine Maleate Review and Irsogladine Maleate Label ), AMEZINIUM METILSULFATE (Unk) (View Amezinium Metilsulfate Review and Amezinium Metilsulfate Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), CARBOCISTEINE (Unk) (View Carbocisteine Review and Carbocisteine Label ).


5706011-8 | Hyperhidrosis, Hypotension, Visual Acuity Reduced
on Apr 04, 2008 Male patient from ITALY , 76 years of age, was diagnosed with hypertensive cardiomyopathy and was treated with Nitroderm (View Usage). Patient had the following side effects: hyperhidrosis, hypotension, visual acuity reduced. Nitroderm dosage: 10 Mg/day. During the same period patient was treated with CONGESCOR (2.5 Mg, Unk) (View Congescor Review and Congescor Label ), AMIODAR (200 Mg, Unk) (View Amiodar Review and Amiodar Label ), LIMPIDEX (15 Mg, Unk) (View Limpidex Review and Limpidex Label ), COUMADIN (5 Mg, Unk) (View Coumadin Review and Coumadin Label ), LASIX (25 Mg, Unk) (View Lasix Review and Lasix Label ), KANRENOL (200 Mg, Unk) (View Kanrenol Review and Kanrenol Label ).

5643041-9 | Abdominal Pain, Atrial Fibrillation, Blood Glucose Increased, Bundle Branch Block Right, Cardiac Massage, Creatinine Renal Clearance Decreased, Diarrhoea, Dizziness, Hypotension
Patient was taking Nitroderm (View Usage). After Nitroderm was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), atrial fibrillation (What is atrial fibrillation?), blood glucose increased, bundle branch block right, cardiac massage, creatinine renal clearance decreased, diarrhoea, dizziness (What is dizziness?), hypotension on Feb 20, 2008 from FRANCE Additional patient health information: Female patient , 85 years of age, was diagnosed with pain (What is pain?), constipation (What is constipation?), hypertension, dementia alzheimer's type, open angle glaucoma and. Nitroderm dosage: 15 Mg/24hours. During the same period patient was treated with DAFALGAN (1000 Mg, Tid) (View Dafalgan Review and Dafalgan Label ), FORLAX (20 G, Qd) (View Forlax Review and Forlax Label ), KARDEGIC (75 Mg, Qd) (View Kardegic Review and Kardegic Label ), ENALAPRIL MALEATE (10 Mg, Qd) (View Enalapril Maleate Review and Enalapril Maleate Label ), FUROSEMIDE (125 Mg/day) (View Furosemide Review and Furosemide Label ), ARICEPT (10 Mg, Qd) (View Aricept Review and Aricept Label ), BIMATOPROST (1 Drp, Qd) (View Bimatoprost Review and Bimatoprost Label ). Patient was hospitalized.

5592862-X | Infarction, Pneumonia
Adverse event was reported on Jan 14, 2008 by a Male patient taking Nitroderm (View Usage) (Dosage: 10 Mg/day) was diagnosed with angina pectoris, hypertension, memory impairment, back pain (What is back pain?) and. Location: BRAZIL , 87 years of age, weighting 180.8 lb, Patient experienced the following unwanted or unexpected effects: infarction, pneumonia (What is pneumonia?). During the same period patient was treated with ATENOLOL (1 Tablet/day) (View Atenolol Review and Atenolol Label ), GINKGO BILOBA (1 Tablet/day) (View Ginkgo Biloba Review and Ginkgo Biloba Label ), BIOFENAC (View Biofenac Review and Biofenac Label ), ATRACURIUM BESYLATE (View Atracurium Besylate Review and Atracurium Besylate Label ). Patient was hospitalized.

5589213-3 | Areflexia, Confusional State, Disorientation, Drain Of Cerebral Subdural Space, Fall, Glasgow Coma Scale Abnormal, Motor Dysfunction, Mydriasis, Subdural Haematoma
on Jan 04, 2008 Male patient from FRANCE , 89 years of age, was treated with Nitroderm (View Usage). Patient had the following side effects: areflexia, confusional state, disorientation, drain of cerebral subdural space, fall (What is fall?), glasgow coma scale abnormal, motor dysfunction, mydriasis, subdural haematoma. Nitroderm dosage: 15 Mg, Qd. During the same period patient was treated with ASPEGIC 325 (View Aspegic 325 Review and Aspegic 325 Label ), BURINEX (3 Mg/day) (View Burinex Review and Burinex Label ), POTASSIUM CHLORIDE (1 Df, Qd) (View Potassium Chloride Review and Potassium Chloride Label ), MOPRAL (20 Mg, Qd) (View Mopral Review and Mopral Label ), IKOREL (20 Mg, Qd) (View Ikorel Review and Ikorel Label ), ELISOR (40 Mg, Qd) (View Elisor Review and Elisor Label ). Patient was hospitalized.

5572869-9 | Infarction, Pneumonia
on Dec 20, 2007 Male patient from BRAZIL , 87 years of age, weighting 180.8 lb, was diagnosed with angina pectoris, hypertension, memory impairment and was treated with Nitroderm (View Usage). After Nitroderm was administered, patient had the following side effects: infarction, pneumonia (What is pneumonia?). Nitroderm dosage: 10 Mg/day. During the same period patient was treated with ATENOLOL (1 Tablet/day) (View Atenolol Review and Atenolol Label ), GINKGO BILOBA (1 Tablet/day) (View Ginkgo Biloba Review and Ginkgo Biloba Label ). Patient was hospitalized.

5526202-9 | Arteriospasm Coronary, Cardiac Arrest, Stress Echocardiogram
Patient was taking Nitroderm (View Usage). Patient experienced the following unwanted or unexpected effects: arteriospasm coronary, cardiac arrest (What is cardiac arrest?), stress echocardiogram on Nov 19, 2007 from KOREA, REPUBLIC OF Additional patient health information: Male patient , 61 years of age, . Nitroderm dosage: .

5512185-4 | Arteriospasm Coronary, Cardiac Arrest, Stress Echocardiogram
Adverse event was reported on Nov 02, 2007 by a Male patient taking Nitroderm (View Usage) (Dosage: ) . Location: KOREA, REPUBLIC OF , 61 years of age, Patient had the following side effects: arteriospasm coronary, cardiac arrest (What is cardiac arrest?), stress echocardiogram.

5441324-9 | Anaphylactic Reaction, Bronchospasm, Condition Aggravated, Hypotension, Intubation, Malaise, Respiratory Failure, Stridor, Tachypnoea
on Aug 30, 2007 Female patient from SWITZERLAND , 86 years of age, was diagnosed with hypertension and was treated with Nitroderm (View Usage). After Nitroderm was administered, patient had the following side effects: anaphylactic reaction, bronchospasm, condition aggravated, hypotension, intubation, malaise, respiratory failure, stridor, tachypnoea. Nitroderm dosage: 1 Patch/day. During the same period patient was treated with DILATREND (25 Mg/day) (View Dilatrend Review and Dilatrend Label ), ADALAT SLOW RELEASE (40 Mg/day) (View Adalat - Slow Release Review and Adalat - Slow Release Label ), RENITEN (10 Mg/day) (View Reniten Review and Reniten Label ), ASPIRIN (100 Mg/day) (View Aspirin Review and Aspirin Label ), LASIX (40 Mg/day) (View Lasix Review and Lasix Label ), SORTIS (10 Mg/day) (View Sortis Review and Sortis Label ). Patient was hospitalized.

5418377-7 | Delirium
on Aug 10, 2007 Male patient from JAPAN , 89 years of age, weighting 105.8 lb, was diagnosed with angina pectoris, constipation (What is constipation?), renal failure, pruritus, pleurisy, gastritis, insomnia and was treated with Nitroderm (View Usage). Patient experienced the following unwanted or unexpected effects: delirium. Nitroderm dosage: . During the same period patient was treated with PURSENNID (View Pursennid Review and Pursennid Label ), FOLIAMIN (View Foliamin Review and Foliamin Label ), CALTAN (View Caltan Review and Caltan Label ), CELTECT (View Celtect Review and Celtect Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ).

5406260-2 | Uterine Haemorrhage, Uterine Hypotonus
Patient was taking Nitroderm (View Usage). Patient had the following side effects: uterine haemorrhage, uterine hypotonus on Aug 01, 2007 from JAPAN Additional patient health information: Female patient , 40 years of age, weighting 143.3 lb, was diagnosed with electrocardiogram st segment depression and. Nitroderm dosage: 2 Df/day. During the same period patient was treated with METHERGINE (0.2 Mg, Unk) (View Methergine Review and Methergine Label ), OXYTOCIN (10 Iu, Unk) (View Oxytocin Review and Oxytocin Label ).

5406093-7 | Blood Pressure Decreased, Chest Discomfort, Electrocardiogram St Segment Depression, Metrorrhagia, Tachycardia, Uterine Haemorrhage, Uterine Hypotonus
Adverse event was reported on Aug 01, 2007 by a Female patient taking Nitroderm (View Usage) (Dosage: 50 Mg, Unk) was diagnosed with angina pectoris, uterine atony, sedation, analgesia and. Location: JAPAN , 41 years of age, weighting 142.2 lb, After Nitroderm was administered, patient had the following side effects: blood pressure decreased, chest discomfort, electrocardiogram st segment depression, metrorrhagia, tachycardia, uterine haemorrhage, uterine hypotonus. During the same period patient was treated with METENARIN (0.4 Mg, Unk) (View Metenarin Review and Metenarin Label ), BUPRENORPHINE HCL (View Buprenorphine Hcl Review and Buprenorphine Hcl Label ), ATONIN O (10 Iu, Unk) (View Atonin-o Review and Atonin-o Label ), PROSTAGLANDIN F2 ALPHA (1 Mg, Unk) (View Prostaglandin F2 Alpha Review and Prostaglandin F2 Alpha Label ), NIZATIDINE (10 Mg, Unk) (View Nizatidine Review and Nizatidine Label ), KN SOL. 3B (200 Ml, Unk) (View Kn Sol. 3b Review and Kn Sol. 3b Label ), DORMICUM (0.5 Mg, Unk) (View Dormicum Review and Dormicum Label ), STADOL (0.5 Mg, Unk) (View Stadol Review and Stadol Label ).

5398890-1 | Uterine Haemorrhage, Uterine Hypotonus
on Jul 20, 2007 Female patient from JAPAN , 40 years of age, weighting 143.3 lb, was diagnosed with electrocardiogram st segment depression and was treated with Nitroderm (View Usage). Patient experienced the following unwanted or unexpected effects: uterine haemorrhage, uterine hypotonus. Nitroderm dosage: 2 Df/day. During the same period patient was treated with METHERGINE (0.2 Mg, Unk) (View Methergine Review and Methergine Label ), OXYTOCIN (10 Iu, Unk) (View Oxytocin Review and Oxytocin Label ).

5382603-3 | Uterine Haemorrhage, Uterine Hypotonus
on Jul 02, 2007 Female patient from JAPAN , 40 years of age, weighting 142.2 lb, was diagnosed with electrocardiogram st segment depression and was treated with Nitroderm (View Usage). Patient had the following side effects: uterine haemorrhage, uterine hypotonus. Nitroderm dosage: 2 Df/day. During the same period patient was treated with METHERGINE (0.2 Mg, Unk) (View Methergine Review and Methergine Label ), OXYTOCIN (10 Iu, Unk) (View Oxytocin Review and Oxytocin Label ).

5377322-3 | Epilepsy
Patient was taking Nitroderm (View Usage). After Nitroderm was administered, patient had the following side effects: epilepsy (What is epilepsy?) on May 08, 2007 from JAPAN Additional patient health information: Male patient , weighting 132.3 lb, was diagnosed with angina pectoris, gastric ulcer, hyperlipidaemia, chronic obstructive pulmonary disease, dementia (What is dementia?), delirium, hypothyroidism, cerebral infarction and. Nitroderm dosage: 25 Mg. During the same period patient was treated with ZANTAC (View Zantac Review and Zantac Label ), MEVALOTIN (10 Mg) (View Mevalotin Review and Mevalotin Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), ERYTHROCIN (View Erythrocin Review and Erythrocin Label ), ARICEPT D (5 Mg) (View Aricept D Review and Aricept D Label ), GRAMALIL (25 Mg) (View Gramalil Review and Gramalil Label ), THYRADIN S (12.5 Mcg) (View Thyradin S Review and Thyradin S Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

5373222-3 | Uterine Haemorrhage, Uterine Hypotonus
Adverse event was reported on Jun 20, 2007 by a Female patient taking Nitroderm (View Usage) (Dosage: 2 Df/day) was diagnosed with electrocardiogram st segment depression and. Location: JAPAN , 40 years of age, weighting 142.2 lb, Patient experienced the following unwanted or unexpected effects: uterine haemorrhage, uterine hypotonus. During the same period patient was treated with METHERGINE (0.2 Mg, Unk) (View Methergine Review and Methergine Label ), OXYTOCIN (10 Iu, Unk) (View Oxytocin Review and Oxytocin Label ).

5314262-X | Epilepsy
on Apr 25, 2007 Male patient from JAPAN , weighting 132.3 lb, was diagnosed with angina pectoris, gastric ulcer, hyperlipidaemia, chronic obstructive pulmonary disease, dementia (What is dementia?), delirium, hypothyroidism, cerebral infarction and was treated with Nitroderm (View Usage). Patient had the following side effects: epilepsy (What is epilepsy?). Nitroderm dosage: 25 Mg. During the same period patient was treated with ZANTAC (View Zantac Review and Zantac Label ), MEVALOTIN (10 Mg) (View Mevalotin Review and Mevalotin Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), ERYTHROCIN (View Erythrocin Review and Erythrocin Label ), ARICEPT D (5 Mg) (View Aricept D Review and Aricept D Label ), GRAMALIL (25 Mg) (View Gramalil Review and Gramalil Label ), THYRADIN S (12.5 Mcg) (View Thyradin S Review and Thyradin S Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

5302463-6 | Pancytopenia, Platelet Count Decreased, White Blood Cell Count Decreased
on Apr 06, 2007 Male patient from JAPAN , 67 years of age, was diagnosed with angina pectoris and was treated with Nitroderm (View Usage). After Nitroderm was administered, patient had the following side effects: pancytopenia, platelet count decreased, white blood cell count decreased. Nitroderm dosage: 1 Df/day. During the same period patient was treated with FLUITRAN (2 Mg, Unk) (View Fluitran Review and Fluitran Label ), MUCODYNE (1500 Mg, Unk) (View Mucodyne Review and Mucodyne Label ), LASIX (20 Mg, Unk) (View Lasix Review and Lasix Label ).

5297537-2 | Back Pain, Electrocardiogram Abnormal
Patient was taking Nitroderm (View Usage). Patient experienced the following unwanted or unexpected effects: back pain (What is back pain?), electrocardiogram abnormal on Apr 03, 2007 from SPAIN Additional patient health information: Male patient , 83 years of age, was diagnosed with infarction and. Nitroderm dosage: . Patient was hospitalized.

5278740-4 | Cerebral Infarction
Adverse event was reported on Mar 16, 2007 by a Female patient taking Nitroderm (View Usage) (Dosage: ) was diagnosed with angina pectoris, dizziness (What is dizziness?), constipation (What is constipation?), iron deficiency anaemia, large intestine carcinoma and. Location: JAPAN , weighting 130.1 lb, Patient had the following side effects: cerebral infarction. During the same period patient was treated with MERISLON (View Merislon Review and Merislon Label ), LAC B (View Lac-b Review and Lac-b Label ), FERROMIA (View Ferromia Review and Ferromia Label ), SEROTONE (View Serotone Review and Serotone Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), FLUOROURACIL (600mg/body=400mg/m2 In Bolus Then 900mg/body=600mg/m2 As Continuous Infusion On Day 1 + 2) (View Fluorouracil Review and Fluorouracil Label ), ISOVORIN (View Isovorin Review and Isovorin Label ), DECADRON (View Decadron Review and Decadron Label ).

5188799-0 | Blood Creatinine Increased, Blood Urea Increased, Cardiac Arrest, Dehydration, Diabetes Mellitus Inadequate Control, Diabetic Coma
on Dec 15, 2006 Female patient from FRANCE , 85 years of age, was diagnosed with ill-defined disorder and was treated with Nitroderm (View Usage). After Nitroderm was administered, patient had the following side effects: blood creatinine increased, blood urea increased, cardiac arrest (What is cardiac arrest?), dehydration, diabetes mellitus inadequate control, diabetic coma. Nitroderm dosage: . During the same period patient was treated with PERINDOPRIL ERBUMINE (Daily Dose: 2 Milligram(s)) (View Perindopril Erbumine Review and Perindopril Erbumine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LASIX (Daily Dose: 40 Milligram(s)) (View Lasix Review and Lasix Label ), DIFFU K (View Diffu K Review and Diffu K Label ), ACTRAPID HUMAN (View Actrapid Human Review and Actrapid Human Label ), LANTUS (View Lantus Review and Lantus Label ), NOVONORM (Daily Dose: 3 Milligram(s)) (View Novonorm Review and Novonorm Label ).

5187915-4 | Antinuclear Antibody Positive, Dermatitis Psoriasiform, Dna Antibody Positive, Lichenoid Keratosis, Pruritus, Psoriasis, Toxic Skin Eruption
on Dec 11, 2006 Female patient from FRANCE , 60 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Nitroderm (View Usage). Patient experienced the following unwanted or unexpected effects: antinuclear antibody positive, dermatitis psoriasiform, dna antibody positive, lichenoid keratosis, pruritus, psoriasis, toxic skin eruption. Nitroderm dosage: 1 Df, Qd. During the same period patient was treated with ALLOPURINOL (300 Mg, Qd) (View Allopurinol Review and Allopurinol Label ), GLIMEPIRIDE (4 Mg, Qd) (View Glimepiride Review and Glimepiride Label ), ZOCOR (20 Mg, Qd) (View Zocor Review and Zocor Label ), TRIATEC (5 Mg, Qd) (View Triatec Review and Triatec Label ), ASPIRIN (160 Mg, Qd) (View Aspirin Review and Aspirin Label ), UMULINE (View Umuline Review and Umuline Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

5164491-3 | Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Cholestasis, Cytolytic Hepatitis, Gamma-glutamyltransferase Increased, Jaundice
Patient was taking Nitroderm (View Usage). Patient had the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, cholestasis, cytolytic hepatitis, gamma-glutamyltransferase increased, jaundice (What is jaundice?) on Nov 22, 2006 from FRANCE Additional patient health information: Male patient , 81 years of age, . Nitroderm dosage: 5 Mg, Qd. During the same period patient was treated with LASIX (2 Df/day) (View Lasix Review and Lasix Label ), ATHYMIL (100 Mg/day) (View Athymil Review and Athymil Label ), INSULATARD NPH HUMAN (12 Ui/day) (View Insulatard Nph Human Review and Insulatard Nph Human Label ), NEXIUM (1 Df, Qd) (View Nexium Review and Nexium Label ), CORDARONE (200 Mg, Qd) (View Cordarone Review and Cordarone Label ), DIFFU K (3 Df/day) (View Diffu K Review and Diffu K Label ). Patient was hospitalized.

5153048-6 | Abscess, Osteonecrosis, Surgery, Swelling, Wound Debridement
Adverse event was reported on Nov 07, 2006 by a Female patient taking Nitroderm (View Usage) (Dosage: ) . Location: FRANCE , 80 years of age, After Nitroderm was administered, patient had the following side effects: abscess (What is abscess?), osteonecrosis (What is osteonecrosis?), surgery (What is surgery?), swelling, wound debridement. During the same period patient was treated with KALEORID (View Kaleorid Review and Kaleorid Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), LASIX (View Lasix Review and Lasix Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), HEMIGOXINE (View Hemigoxine Review and Hemigoxine Label ), CELECTOL (View Celectol Review and Celectol Label ), CACIT D3 (View Cacit D3 Review and Cacit D3 Label ). Patient was hospitalized.

5066576-9 | Alanine Aminotransferase Increased, Anaemia, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Creatine Phosphokinase Increased, Blood Creatine Phosphokinase Mb, Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, C-reactive Protein Increased
on Jul 24, 2006 Male patient from FRANCE , 71 years of age, weighting 77.99 lb, was diagnosed with hypertension, delusional disorder, persecutory type, hypercholesterolaemia, diabetes mellitus and was treated with Nitroderm (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood creatine phosphokinase mb, blood creatinine increased, blood lactate dehydrogenase increased, c-reactive protein increased. Nitroderm dosage: 1 Df, Qd. During the same period patient was treated with ZYPREXA (View Zyprexa Review and Zyprexa Label ), VASTEN (20 Mg, Qd) (View Vasten Review and Vasten Label ), ZESTRIL (20 Mg, Qd) (View Zestril Review and Zestril Label ), INSULATARD NPH HUMAN (32 Iu, Qd) (View Insulatard Nph Human Review and Insulatard Nph Human Label ), AMLODIPINE BESYLATE (5 Mg, Bid) (View Amlodipine Besylate Review and Amlodipine Besylate Label ).

5060608-X | Fracture, Hypertension, Injury
on Jul 14, 2006 Female patient from SWITZERLAND , 75 years of age, was treated with Nitroderm (View Usage). Patient had the following side effects: fracture (What is fracture?), hypertension, injury. Nitroderm dosage: 10 Mg/day. During the same period patient was treated with PERLINGANIT (View Perlinganit Review and Perlinganit Label ), TRAMADOL HCL (Unk, Unk) (View Tramadol Hcl Review and Tramadol Hcl Label ), DILZEM (120 Mg, Bid) (View Dilzem Review and Dilzem Label ), MYSOLINE (250 Mg, Tid) (View Mysoline Review and Mysoline Label ), VALPROIC ACID (500 Mg, Tid) (View Valproic Acid Review and Valproic Acid Label ), VITARUBIN (1 Mg/week) (View Vitarubin Review and Vitarubin Label ). Patient was hospitalized.

4918463-1 | Alanine Aminotransferase Increased, Angina Pectoris, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase, Blood Lactate Dehydrogenase Increased, Blood Pressure Inadequately Controlled, Diabetes Mellitus Inadequate Control, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal
Patient was taking Nitroderm (View Usage). After Nitroderm was administered, patient had the following side effects: alanine aminotransferase increased, angina pectoris, aspartate aminotransferase increased, blood alkaline phosphatase, blood lactate dehydrogenase increased, blood pressure inadequately controlled, diabetes mellitus inadequate control, gamma-glutamyltransferase increased, hepatic function abnormal on Feb 08, 2006 from FRANCE Additional patient health information: Female patient , 78 years of age, weighting 176.4 lb, was diagnosed with angina pectoris, gastric ulcer, arthralgia, urinary tract infection (What is urinary tract infection?) and. Nitroderm dosage: 1 Df, Daily. During the same period patient was treated with OMEPRAZOLE (40 Mg Daily) (View Omeprazole Review and Omeprazole Label ), VASTAREL ^BIOPHARMA^ (View Vastarel ^biopharma^ Review and Vastarel ^biopharma^ Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ), MOLSIDOMINE (View Molsidomine Review and Molsidomine Label ), FENOFIBRATE (View Fenofibrate Review and Fenofibrate Label ), BI PROFENID (300 Mg Daily) (View Bi-profenid Review and Bi-profenid Label ), BACTRIM DS (2 Df Daily) (View Bactrim Ds Review and Bactrim Ds Label ). Patient was hospitalized.

4915016-6 | Memory Impairment
Adverse event was reported on Feb 07, 2006 by a Female patient taking Nitroderm (View Usage) (Dosage: ) . Location: AUSTRALIA , 81 years of age, Patient experienced the following unwanted or unexpected effects: memory impairment. Patient was hospitalized.

4896183-X | Cholestasis, Cytolytic Hepatitis, Dermatitis, Diarrhoea, Eosinophilia, Hepatic Encephalopathy, Hepatic Enzyme Increased, Hepatitis Fulminant, Hepatocellular Damage
on Jan 26, 2006 Male patient from FRANCE , 65 years of age, was treated with Nitroderm (View Usage). Patient had the following side effects: cholestasis, cytolytic hepatitis, dermatitis, diarrhoea, eosinophilia, hepatic encephalopathy, hepatic enzyme increased, hepatitis fulminant, hepatocellular damage. Nitroderm dosage: . During the same period patient was treated with ESIDRIX (View Esidrix Review and Esidrix Label ), COTAREG (View Cotareg Review and Cotareg Label ), NOCTRAN (View Noctran Review and Noctran Label ), DIFFU K (View Diffu K Review and Diffu K Label ), SULFAMETHOXAZOLE W/TRIMETHOPRIM (COTRIMOXAZOLE) (View Sulfamethoxazole W/trimethoprim (cotrimoxazole) Review and Sulfamethoxazole W/trimethoprim (cotrimoxazole) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), OGAST (View Ogast Review and Ogast Label ), DIGOXIN (View Digoxin Review and Digoxin Label ). Patient was hospitalized.

4888222-7 | Blood Glucose Decreased, Cold Sweat, Dizziness, Hepatitis Acute, Hypoglycaemia, Speech Disorder, Yawning
on Jan 05, 2006 Female patient from JAPAN , 87 years of age, was diagnosed with cardiac failure and was treated with Nitroderm (View Usage). After Nitroderm was administered, patient had the following side effects: blood glucose decreased, cold sweat, dizziness (What is dizziness?), hepatitis acute, hypoglycaemia, speech disorder, yawning. Nitroderm dosage: . During the same period patient was treated with ARTIST (View Artist Review and Artist Label ), THYRADIN (View Thyradin Review and Thyradin Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), DIART (View Diart Review and Diart Label ), ACARDI (View Acardi Review and Acardi Label ), DORNER (View Dorner Review and Dorner Label ), DIOVAN (80 Mg/day) (View Diovan Review and Diovan Label ). Patient was hospitalized.

4884434-7 | Blood Glucose Decreased, Cold Sweat, Dizziness, Hepatitis Acute, Hypoglycaemia, Speech Disorder, Yawning
Patient was taking Nitroderm (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, cold sweat, dizziness (What is dizziness?), hepatitis acute, hypoglycaemia, speech disorder, yawning on Jan 05, 2006 from JAPAN Additional patient health information: Female patient , 87 years of age, was diagnosed with cardiac failure and. Nitroderm dosage: . During the same period patient was treated with ARTIST (View Artist Review and Artist Label ), THYRADIN (View Thyradin Review and Thyradin Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), DIART (View Diart Review and Diart Label ), ACARDI (View Acardi Review and Acardi Label ), DORNER (View Dorner Review and Dorner Label ), DIOVAN (80 Mg/day) (View Diovan Review and Diovan Label ). Patient was hospitalized.

4832804-5 | Abdominal Pain Upper, Anaemia, Barrett's Oesophagus, Duodenitis, Gastrointestinal Fungal Infection, Gastrointestinal Haemorrhage, Haematemesis, Haemoglobin Decreased, Oesophagitis
Adverse event was reported on Nov 10, 2005 by a Male patient taking Nitroderm (View Usage) (Dosage: 1 Df, Bid) was diagnosed with acute myocardial infarction, oesophagitis, hypertension, diabetes mellitus and. Location: FRANCE , 69 years of age, Patient had the following side effects: abdominal pain upper, anaemia, barrett's oesophagus, duodenitis, gastrointestinal fungal infection, gastrointestinal haemorrhage, haematemesis, haemoglobin decreased, oesophagitis. During the same period patient was treated with ESOMEPRAZOLE (INEXIUM) (1 Df, Bid) (View Esomeprazole (inexium) Review and Esomeprazole (inexium) Label ), PLAVIX (View Plavix Review and Plavix Label ), LOXEN LP (50 Mg, Bid) (View Loxen Lp Review and Loxen Lp Label ), SELOKEN (50 Mg, Bid) (View Seloken Review and Seloken Label ), AMAREL (View Amarel Review and Amarel Label ). Patient was hospitalized.

4785979-0 | Campylobacter Intestinal Infection, Faeces Discoloured
on Sep 23, 2005 Male patient from AUSTRALIA , 94 years of age, was diagnosed with myocardial ischaemia, left ventricular failure, hypertension and was treated with Nitroderm (View Usage). After Nitroderm was administered, patient had the following side effects: campylobacter intestinal infection, faeces discoloured. Nitroderm dosage: 25 Mg, Qd. During the same period patient was treated with CEFTRIAXONE (1 G, Qd) (View Ceftriaxone Review and Ceftriaxone Label ), ROXITHROMYCIN (300 Mg, Qd) (View Roxithromycin Review and Roxithromycin Label ), FUROSEMIDE (40 Mg, Qd) (View Furosemide Review and Furosemide Label ), PRAZOSIN HCL (6 Mg, Qd) (View Prazosin Hcl Review and Prazosin Hcl Label ), IMDUR (120 Mg, Qd) (View Imdur Review and Imdur Label ), ATENOLOL (75 Mg, Qd) (View Atenolol Review and Atenolol Label ), NIFEDIPINE (20 Mg, Qd) (View Nifedipine Review and Nifedipine Label ). Patient was hospitalized.

4772590-0 | Angina Pectoris, Condition Aggravated, Eosinophil Count Increased, Eosinophilia, Erythema, Pruritus, Rash
on Aug 11, 2005 Female patient from JAPAN , 56 years of age, weighting 123.5 lb, was diagnosed with angina pectoris and was treated with Nitroderm (View Usage). Patient experienced the following unwanted or unexpected effects: angina pectoris, condition aggravated, eosinophil count increased, eosinophilia, erythema, pruritus, rash (What is rash?). Nitroderm dosage: 25 Mg, Qd. During the same period patient was treated with SIGMART (10 Mg, Unk) (View Sigmart Review and Sigmart Label ), HERBESSER (30 Mg, Qid) (View Herbesser Review and Herbesser Label ). Patient was hospitalized.

4749539-X | Condition Aggravated, Eosinophil Count Increased, Rash
Patient was taking Nitroderm (View Usage). Patient had the following side effects: condition aggravated, eosinophil count increased, rash (What is rash?) on Aug 11, 2005 from JAPAN Additional patient health information: Female patient , 56 years of age, was diagnosed with angina pectoris and. Nitroderm dosage: 25 Mg, Qd. During the same period patient was treated with SIGMART (10 Mg, Unk) (View Sigmart Review and Sigmart Label ), HERBESSER (30 Mg, Qid) (View Herbesser Review and Herbesser Label ). Patient was hospitalized.

4746661-9 | Ageusia, Atrioventricular Block Complete, Myocardial Infarction
Adverse event was reported on Aug 05, 2005 by a Male patient taking Nitroderm (View Usage) (Dosage: 1 Patch Qd) was diagnosed with hypertension, cardiac disorder and. Location: SWITZERLAND , 95 years of age, After Nitroderm was administered, patient had the following side effects: ageusia, atrioventricular block complete, myocardial infarction. During the same period patient was treated with CANDESARTAN (4 Mg/day) (View Candesartan Review and Candesartan Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ASPIRIN (100 Mg/day) (View Aspirin Review and Aspirin Label ), DANCOR (10 Mg /day) (View Dancor Review and Dancor Label ), TORSEMIDE (5 Mg/day) (View Torsemide Review and Torsemide Label ).

4746660-7 | Alpha 2 Globulin Increased, Electrophoresis Protein Abnormal, Hypoalbuminaemia, Leukocytoclastic Vasculitis, Purpura
on Aug 05, 2005 Female patient from FRANCE , 84 years of age, was treated with Nitroderm (View Usage). Patient experienced the following unwanted or unexpected effects: alpha 2 globulin increased, electrophoresis protein abnormal, hypoalbuminaemia, leukocytoclastic vasculitis, purpura. Nitroderm dosage: 10 Mg/day. During the same period patient was treated with PIPRAM (400 Mg, Bid) (View Pipram Review and Pipram Label ), DITROPAN (2.5 Mg, Bid) (View Ditropan Review and Ditropan Label ), SECTRAL (100 Mg, Bid) (View Sectral Review and Sectral Label ), ZOLOFT (50 Mg/day) (View Zoloft Review and Zoloft Label ), RISPERDAL (0.5 Mg/day) (View Risperdal Review and Risperdal Label ), SPASFON LYOC (View Spasfon-lyoc Review and Spasfon-lyoc Label ), LORAZEPAM (1.5 Mg/day) (View Lorazepam Review and Lorazepam Label ), ACETAMINOPHEN (3 G/day) (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

4746659-0 | Inflammation, Vascular Purpura
on Aug 05, 2005 Male patient from FRANCE , 75 years of age, was treated with Nitroderm (View Usage). Patient had the following side effects: inflammation, vascular purpura. Nitroderm dosage: 5 Mg/day. During the same period patient was treated with TAREG (160 Mg/day) (View Tareg Review and Tareg Label ), PREVISCAN (View Previscan Review and Previscan Label ), LEVOTHYROX (100 Ug/day) (View Levothyrox Review and Levothyrox Label ), LASIX (40 Mg/day) (View Lasix Review and Lasix Label ), CORDARONE (200 Mg, Qw5) (View Cordarone Review and Cordarone Label ), IMOVANE (1 Df, Qd) (View Imovane Review and Imovane Label ), DIFFU K (View Diffu K Review and Diffu K Label ), HUMALOG (View Humalog Review and Humalog Label ). Patient was hospitalized.

4696320-6 | Pancytopenia
Patient was taking Nitroderm (View Usage). After Nitroderm was administered, patient had the following side effects: pancytopenia on Jun 09, 2005 from Additional patient health information: Male patient , 88 years of age, was diagnosed with angina pectoris and. Nitroderm dosage: . Patient was hospitalized.

4598724-9 | Cerebrovascular Accident, Hypotension
Adverse event was reported on Oct 07, 2004 by a Female patient taking Nitroderm (View Usage) (Dosage: 1 Df/day) was diagnosed with hypertension, cardiac disorder, coagulopathy and. Location: , 84 years of age, weighting 198.4 lb, Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, hypotension. During the same period patient was treated with ENALAPRIL MALEATE (2 Caps/day) (View Enalapril Maleate Review and Enalapril Maleate Label ), LASIX (1 Cap/day) (View Lasix Review and Lasix Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), NOREVAN (0.25 Cap/day) (View Norevan Review and Norevan Label ).

4587103-6 | Cerebrovascular Accident, Hypotension
on Oct 07, 2004 Female patient from , 84 years of age, weighting 198.4 lb, was diagnosed with vasodilatation, hypertension, cardiac disorder, coagulopathy and was treated with Nitroderm (View Usage). Patient had the following side effects: cerebrovascular accident, hypotension. Nitroderm dosage: 1 Df/day. During the same period patient was treated with ENALAPRIL MALEATE (2 Caps/day) (View Enalapril Maleate Review and Enalapril Maleate Label ), LASIX (1 Cap/day) (View Lasix Review and Lasix Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), NOREVAN (0.25 Cap/day) (View Norevan Review and Norevan Label ).

4561139-3 | Respiratory Failure
on Jan 24, 2005 Female patient from , 88 years of age, was treated with Nitroderm (View Usage). After Nitroderm was administered, patient had the following side effects: respiratory failure. Nitroderm dosage: Unk, Unk. During the same period patient was treated with DURAGESIC (View Duragesic Review and Duragesic Label ), SEVREDOL (View Sevredol Review and Sevredol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), TRYPTIZOL (View Tryptizol Review and Tryptizol Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).